Companies, News, Discussion, and Investing.

marijuana News

marijuana
Marijuana Stocks is happy to bring you a growing list of the world’s publicly traded marijuana focused companies, as well as news, resources, event listings, and general discussion about investing in the marijuana sector. If you do not see your company on our list, please contact us to have it listed.

Abattis Names Jaouad Fichtali as Chief Technology Officer

Posted In: News| Posted On:Nov 19, 2014 No Comment

Vancouver, BC – November 17, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Jaouad Fichtali will assume the role of Chief Technology Officer of Read More

Abattis Obtains Emergency Temporary Restraining Order Against Defendants In King County, Washington State Court–Court Sets 'Show Cause' Hearing Against Defendants For November 24 Regarding The Imposition Of A Preliminary Injunction

Posted In: News| Posted On:Nov 11, 2014 No Comment

Vancouver, BC — November 11, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, wishes to advise its shareholders that Read More

Abattis Legal Proceedings Update

Posted In: News| Posted On:Nov 10, 2014 No Comment

Vancouver, BC – November 7, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that the U.S. Federal Court in Washington State has this morning declined to exercise federal jurisdiction over the Company’s recently announced claims. As a preliminary jurisdictional matter, the court indicated that it Read More

Abattis Legal Action Goes from Federal to Washington State Court

Posted In: News| Posted On:Nov 10, 2014 No Comment

Vancouver, BC – November 10, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that end of day Friday November 7th the company filed its suit in King County Superior Court, that it had previously filed in Federal court. It was filed end of day Friday. Read More

Abattis Files for Injunctive Relief in Washington State and Claims Damages Against Former Employees, Business Associates and Competitor, Affinor Growers, Inc. and Certain of its Associates

Posted In: News| Posted On:Oct 25, 2014 No Comment

Vancouver, BC – October 24, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), wishes to advise its shareholders that it has today, in U.S. Federal court in Washington State, filed suit for damages and injunctive relief against prior employees of PhytaLab (Dr. Kaleb Lund and Ms. Lauren Hilty), a former Read More

Abattis' Announces New Investor Relations Appointment

Posted In: News| Posted On:Oct 16, 2014 No Comment

Vancouver, BC — October 17, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that they have entered Read More

Abattis Announces Zoning Approval on the Experion MMPR Application

Posted In: News| Posted On:Oct 08, 2014 No Comment

Vancouver, BC — October 8, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that through its wholly owned subsidiary, Northern Vine Canada Inc. (“Northern Vine”), Read More

Abattis Announces Appointment Guy Dancosse, Q.C. to Board of Directors

Posted In: News| Posted On:Sep 16, 2014 No Comment

Vancouver, BC – September 16, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that Guy Dancosse, Q.C. has agreed to join the Board effective immediately Read More

Abattis' Phytalab Receives Cannabis Lab Certification In Washington

Posted In: News| Posted On:Sep 08, 2014 No Comment

Vancouver, BC – September 8th, 2014 – Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTCQX: ATTBF) (CSE: ATT), a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America, today announced that Phytalytics LLC. (“Phytalab.com”), Read More

A Moral Case for Investing in Marijuana

Posted In: Blog| Posted On:Aug 31, 2014 No Comment

If you are like me you have been watching the evolution of the marijuana sector with great interest.  What seems like slowly but one day at a time, the use of marijuana both for medical and recreational purposes is being met with wider acceptance.  And while ‘wider’ is an arbitrary term, never did I expect Read More


Directory powered by Business Directory Plugin